4//SEC Filing
Sharei Armon 4
Accession 0000899243-21-001490
CIK 0001604477other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:30 PM ET
Size
7.2 KB
Accession
0000899243-21-001490
Insider Transaction Report
Form 4
Sharei Armon
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2021-01-08$1.81/sh+2,500$4,525→ 251,713 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-08−2,500→ 203,986 totalExercise: $1.81Exp: 2026-10-10→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]Options were exercised and held for tax planning purposes.
- [F2]The option was originally granted for 286,514 shares. The option vested and and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001829463
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:30 PM ET
- Size
- 7.2 KB